Enhance Access to Kidney Transplantation and Living Kidney Donation

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Kidney DiseasesKidney FailureEnd Stage Renal Disease
Interventions
OTHER

Multicomponent intervention

Patients in 13 of the 26 CKD programs will receive a multicomponent intervention or usual care. The intervention has four main components: (1) support for local quality improvement teams and administrative needs; (2) tailored education and resources for staff, patients, and living kidney donor candidates; (3) support from kidney transplant recipients and living kidney donors; and (4) program-level performance reports and oversight by program leaders.

Trial Locations (1)

N6A5W9

London Health Sciences Centre, London

All Listed Sponsors
collaborator

Institute for Clinical Evaluative Sciences (ICES)

UNKNOWN

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Ontario Renal Network (part of Ontario Health)

UNKNOWN

collaborator

Trillium Gift of Life Network (part of Ontario Health)

UNKNOWN

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03329521 - Enhance Access to Kidney Transplantation and Living Kidney Donation | Biotech Hunter | Biotech Hunter